Growth Opportunity Small privately-held neonatology pharma with revenue in the 25-50M range and recent expansion activity including acquisition of new building. Potential for manufacturing scale-up partnerships, contract manufacturing, or distribution arrangements to support growth and capacity needs.

Product Launch Recent launch of AerVia a next generation supraglottic airway device for neonates signals ongoing product adoption and clinical integration opportunities. Sales potential in hospital procurement, NICUs, and regional distributors as adoption expands.

Strategic Leadership New leadership hires including Chief Medical Officer and Chief Scientific Officer indicate a focus on clinical excellence and R
0D; expansion. Engage for collaborative clinical studies, advisory roles, and sponsor opportunities to co-develop evidence supporting new products.

Geographic Focus USA-born neonatology biotech with global ambitions and a Buffalo NY base. Opportunities to support US and international market access, regulatory consulting, and localized manufacturing or packaging partnerships to support export readiness.

Tech & Compliance Adopted cloud and web optimization tech stack with emphasis on data standards (JSON-LD, Open Graph) and security (X-Content-Type-Options). Indicates readiness for digital partnerships, e-commerce or direct-to-hospital sales enablement platforms with strong data governance.